Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Gross Profit (2016 - 2025)

Surgery Partners' Gross Profit history spans 12 years, with the latest figure at $154.1 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 75.97% year-over-year to $154.1 million; the TTM value through Dec 2025 reached $2.4 billion, changed 0.26%, while the annual FY2025 figure was $2.4 billion, 5.58% up from the prior year.
  • Gross Profit for Q4 2025 was $154.1 million at Surgery Partners, down from $772.5 million in the prior quarter.
  • Across five years, Gross Profit topped out at $1.1 billion in Q4 2023 and bottomed at $114.2 million in Q4 2022.
  • The 5-year median for Gross Profit is $536.8 million (2021), against an average of $562.0 million.
  • The largest annual shift saw Gross Profit tumbled 87.89% in 2022 before it skyrocketed 871.89% in 2023.
  • A 5-year view of Gross Profit shows it stood at $942.7 million in 2021, then crashed by 87.89% to $114.2 million in 2022, then surged by 871.89% to $1.1 billion in 2023, then plummeted by 42.21% to $641.4 million in 2024, then crashed by 75.97% to $154.1 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Gross Profit are $154.1 million (Q4 2025), $772.5 million (Q3 2025), and $770.8 million (Q2 2025).